Rockefeller Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Buy
3,271
+1,088
+50% +$65.3K ﹤0.01% 2585
2025
Q4
$128K Sell
2,183
-943
-30% -$57.3K ﹤0.01% 2590
2025
Q3
$174K Buy
+3,126
New +$167K ﹤0.01% 2301
2023
Q4
Sell
-15,233
Closed -$1.04M 1599
2023
Q3
$1.04M Sell
15,233
-744
-5% -$58.8K ﹤0.01% 1065
2023
Q2
$1.3M Sell
15,977
-4,687
-23% -$377K 0.01% 986
2023
Q1
$1.53M Buy
20,664
+261
+1% +$20.1K 0.01% 915
2022
Q4
$1.69M Sell
20,403
-201
-1% -$16K 0.01% 815
2022
Q3
$1.46M Sell
20,604
-14,720
-42% -$1.27M 0.01% 869
2022
Q2
$3.06M Sell
35,324
-504
-1% -$47.2K 0.02% 642
2022
Q1
$3.88M Sell
35,828
-8,376
-19% -$864K 0.02% 604
2021
Q4
$5.72M Buy
44,204
+5,236
+13% +$642K 0.03% 505
2021
Q3
$4.72M Sell
38,968
-2,492
-6% -$303K 0.02% 496
2021
Q2
$4.67M Buy
41,460
+2,864
+7% +$301K 0.03% 469
2021
Q1
$3.69M Buy
38,596
+28
+0.1% +$2.55K 0.02% 433
2020
Q4
$3.06M Buy
38,568
+6,884
+22% +$499K 0.02% 417
2020
Q3
$1.96M Buy
31,684
+5,688
+22% +$370K 0.02% 428
2020
Q2
$1.72M Buy
25,996
+3,188
+14% +$191K 0.02% 430
2020
Q1
$1.08M Buy
22,808
+19,932
+693% +$997K 0.01% 464
2019
Q4
$158K Sell
2,876
-36
-1% -$1.89K ﹤0.01% 828
2019
Q3
$143K Sell
2,912
-152
-5% -$7.62K ﹤0.01% 698
2019
Q2
$160K Sell
3,064
-1,236
-29% -$62.3K ﹤0.01% 612
2019
Q1
$213K Buy
4,300
+1,332
+45% +$59.9K ﹤0.01% 590
2018
Q4
$107K Hold
2,968
﹤0.01% 452
2018
Q3
$151K Hold
2,968
﹤0.01% 370
2018
Q2
$110K Buy
+2,968
New +$113K ﹤0.01% 375

Other funds holding TECH

Rockefeller Capital Management's TECH Position: Q1 2026 in Review

Rockefeller Capital Management increased its Bio-Techne (TECH) stake by 50% in Q1 2026, buying an estimated $65.3K and bringing the position to 3,271 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Rockefeller Capital Management first reported a position in TECH in Q2 2018 and has held it in 25 quarters since. The position peaked at $5.72M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Rockefeller Capital Management held 3,271 shares of Bio-Techne worth $171K as of Q1 2026.
  • Rockefeller Capital Management bought 1,088 Bio-Techne shares in Q1 2026, an estimated $65.3K.
  • Bio-Techne made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2585 holding.
  • Rockefeller Capital Management first reported a position in Bio-Techne in Q2 2018 and has held it in 25 quarters since.
  • Rockefeller Capital Management's Bio-Techne position peaked at $5.72M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.